Pomerantz Logo

  • The Firm
  • Our People
  • Services
  • Cases
  • News
  • Contact
About Us Firm History Global Expertise Substantial Recoveries Accolades Diversity
Attorneys Staff

Client Services

Portfolio Monitoring Case Evaluation Shareholder Activism

Litigation Services

Securities Litigation Corporate Governance Reform Consumer Fraud Litigation Antitrust
Join an Action Shareholder Alerts Notable Settlements Notable Cases
Latest News Pomerantz Monitor Notices
  • Home
  • The Firm
    • About Us
    • Firm History
    • Global Expertise
    • Substantial Recoveries
    • Accolades
    • Diversity
  • Our People
    • Attorneys
    • Staff
  • Client Services
    • Portfolio Monitoring
    • Case Evaluation
    • Shareholder Activism
  • Litigation Services
    • Securities Litigation
    • Corporate Governance Reform
    • Consumer Fraud Litigation
    • Antitrust
  • Cases
    • Join an Action
    • Shareholder Alerts
    • Notable Settlements
    • Notable Cases
  • News
    • Latest News
    • Pomerantz Monitor
    • Notices
  • Contact
  • Search
News Posts

Pomerantz Achieves Settlement with Fiat Chrysler Automobiles N.V.

Pomerantz achieved a significant victory for investors in Fiat Chrysler on September 5, when U.S. District Judge Jesse M. Furman granted final approval to a $110 million settlement with the automaker. “Counsel has secured a substantial recovery for the class,” the judge said …

Read More

Pomerantz LLP Appointed Lead Counsel in Ascena Retail Group Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Ascena Retail Group, Inc.

Read More

Pomerantz LLP Appointed Lead Counsel in 22nd Century Group Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against 22nd Century Group on behalf of investors.

Read More

Pomerantz LLP Appointed Lead Counsel in Nabriva Therapeutics plc Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Nabriva Therapeutics.

Read More

Pomerantz LLP Appointed Lead Counsel in Boston Scientific Corporation Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Boston Scientific Corporation.

Read More

Pomerantz LLP Appointed Lead Counsel in AT&T Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit on behalf of investors against AT&T Inc.

Read More

Pomerantz LLP Appointed Lead Counsel in Credit Suisse Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against Credit Suisse Group AG on behalf of investors in VelocityShares Daily Inverse VIX MediumTerm exchange-traded notes.

Read More

Pomerantz LLP Appointed Lead Counsel in CenturyLink, Inc. Securities Class Action

On June 10, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action law suit filed against CenturyLink, Inc..

Read More

Pomerantz LLP Appointed Lead Counsel in McDermott International Securities Litigation

On June 5, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit filed against McDermott International.

Read More

Pomerantz Fights Forced Arbitration

Pomerantz’s recently filed intervention motion in a New Jersey federal court litigation marks the first court test of the legality of mandatory shareholder arbitration.

Read More

Pomerantz LLP Appointed Lead Counsel in WuXi PharmaTech (Cayman) Inc. Securities Class Action

On March 28, 2019, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company”) and certain of its officers and directors.

Read More

Pomerantz LLP Appointed Lead Counsel in CVS Health Corporation Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against CVS Health Corporation.

Read More

Pomerantz LLP Appointed Lead Counsel in Aveo Pharmaceuticals Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against Aveo Pharmaceuticals.

Read More

Pomerantz LLP Appointed Lead Counsel in Lewis v. YRC Worldwide Inc. Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against YRC Worldwide, Inc.

Read More

Pomerantz Ranked #1 in 2018 Settlements

Pomerantz LLP was ranked #1 in both Total Settlement Amount and Number of Settlements for 2018 by SCAS.

Read More

Pomerantz LLP Appointed Lead Counsel in Bellicum Pharmaceuticals Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Bellicum Pharmaceuticals, Inc.

Read More

Pomerantz LLP Appointed Lead Counsel in Allergan PLC Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Allergan plc.

Read More

Pomerantz LLP Appointed Lead Counsel in Ormat Technologies, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Ormat Technologies, Inc.

Read More

Pomerantz LLP Appointed Co-Lead Counsel in Philip Morris International Inc. Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action lawsuit filed against Philip Morris International Inc.

Read More

Pomerantz LLP Appointed Lead Counsel in Edison International Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Edison International and certain of its officers.

Read More
Newer Older

© Pomerantz LLP 2024

linkedin twitter facebook instagram
CONTACT